One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis
- PMID: 31570086
- DOI: 10.1161/STROKEAHA.119.026922
One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis
Abstract
Background and Purpose- Intravenous thrombolysis with r-tPA (recombinant tissue-type plasminogen activator) is associated with improved early functional outcome after stroke, but its long-term effects are less understood. We aimed to determine the association between r-tPA and 1-year outcomes after stroke. Methods- We used the Ontario Stroke Registry to identify patients diagnosed with ischemic stroke between 2002 and 2013 in Ontario, Canada, their baseline characteristics, and whether they received r-tPA. We used propensity score methods to match patients treated with r-tPA to nontreated patients. The primary outcome was 1-year home-time, defined as the number of days spent outside of any healthcare institutions in the first 365 days after the index date of admission. Secondary outcomes were admission to a nursing home and all-cause mortality in the first year. Outcomes were determined using linked administrative data. We used paired t tests to compare mean home-time days and Cox proportional hazards models for mortality and nursing home admission to estimate hazard ratios and 95% CI. Results- All 4449 patients treated with r-tPA in the registry were matched to nontreated patients. Compared with nontreated patients, those treated with r-tPA experienced more time at home in the first year (mean±SD was 248.9 days±137.2 treated versus 239.4 days±139.0 nontreated, P=0.005) and were less likely to be admitted to nursing homes (9.4% treated versus 12.2% nontreated; hazard ratio, 0.84; 95% CI, 0.78-0.91). One-year all-cause mortality was similar between the 2 groups (13.2% treated versus 12.4% nontreated; hazard ratio, 1.07; 95% CI, 0.96-1.20). Conclusions- Despite similar mortality, patients who received r-tPA spent more time at home and were less likely to require nursing home admission in the first year after stroke compared with nontreated patients, suggesting long-term benefits and safety of this treatment.
Keywords: Ontario; mortality; nursing home; propensity score; risk.
Comment in
-
Response by Yu and Kapral to Letter Regarding Article, "One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis".Stroke. 2020 Jan;51(1):e18. doi: 10.1161/STROKEAHA.119.028094. Epub 2019 Nov 27. Stroke. 2020. PMID: 31771459 No abstract available.
-
Letter by Cai et al Regarding Article, "One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis".Stroke. 2020 Jan;51(1):e17. doi: 10.1161/STROKEAHA.119.028010. Epub 2019 Nov 27. Stroke. 2020. PMID: 31771462 No abstract available.
Similar articles
-
Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study.Stroke. 2014 Oct;45(10):3070-2. doi: 10.1161/STROKEAHA.114.006570. Epub 2014 Sep 4. Stroke. 2014. PMID: 25190440
-
Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.Int J Stroke. 2016 Oct;11(8):910-916. doi: 10.1177/1747493016654491. Epub 2016 Jul 9. Int J Stroke. 2016. PMID: 27312677
-
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2603-2609. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.044. Epub 2016 Jul 28. J Stroke Cerebrovasc Dis. 2016. PMID: 27476340
-
Endovascular Thrombectomy Alone versus Combined with Intravenous Thrombolysis.World Neurosurg. 2017 Dec;108:850-858.e2. doi: 10.1016/j.wneu.2017.08.040. Epub 2017 Aug 18. World Neurosurg. 2017. PMID: 28823660 Review.
-
Current status of intravenous thrombolysis for acute ischemic stroke in Asia.Int J Stroke. 2011 Dec;6(6):523-30. doi: 10.1111/j.1747-4949.2011.00671.x. Int J Stroke. 2011. PMID: 22111797 Review.
Cited by
-
Identifying Predictors of Nursing Home Admission by Using Electronic Health Records and Administrative Data: Scoping Review.JMIR Aging. 2023 Nov 20;6:e42437. doi: 10.2196/42437. JMIR Aging. 2023. PMID: 37990815 Free PMC article. Review.
-
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke.Neurol Ther. 2023 Aug;12(4):1105-1118. doi: 10.1007/s40120-023-00488-3. Epub 2023 May 11. Neurol Ther. 2023. PMID: 37166676 Free PMC article.
-
The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature.Curr Neurol Neurosci Rep. 2022 Mar;22(3):151-160. doi: 10.1007/s11910-022-01180-z. Epub 2022 Mar 11. Curr Neurol Neurosci Rep. 2022. PMID: 35274192 Free PMC article. Review.
-
Applying Propensity Score Methods in Clinical Research in Neurology.Neurology. 2021 Nov 2;97(18):856-863. doi: 10.1212/WNL.0000000000012777. Epub 2021 Sep 9. Neurology. 2021. PMID: 34504033 Free PMC article.
-
Comparing regression modeling strategies for predicting hometime.BMC Med Res Methodol. 2021 Jul 7;21(1):138. doi: 10.1186/s12874-021-01331-9. BMC Med Res Methodol. 2021. PMID: 34233616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical